Flagship Pioneering was founded to offer an alternative to existing methods of entrepreneurial innovation. The Flagship team conceives, resources, and builds life sciences companies that invent breakthrough technologies, each based on an original product platform, to transform health care and sustainability. Our unique model combines scientific creativity, technological ingenuity, systematic entrepreneurship, executive leadership, professional capital management, and a vast network of expertise into a single institution that produces first-in-category companies though an emergent, evolutionary methodology. We call this process pioneering.Over nearly two decades, this approach has enabled Flagship to originate and foster the development of around 100 science-based companies, resulting in more than $30 billion in aggregate value, thousands of patents, and a pipeline of more than 50 clinical development programs. Flagship has more than $10 billion in private capital raised and managed by the company.

Invaio Sciences is a multi-platform technology company that unlocks the potential of the planet’s interdependent systems to address pressing agricultural, nutritional and environmental challenges. Founded by Flagship Pioneering, Invaio leverages discoveries from diverse fields including human therapeutics, agriculture, environmental science, machine learning, data sciences and advanced manufacturing.

CiBO Technologies is developing an industry-changing online platform to provide objective, scientifically-driven insights to drive efficiency in farmland markets. At CiBO Technologies, we combine science, data, and software to enable agriculture scaling with unbiased information and direct connections. CiBO delivers high value, objective insights around farmland and its potential, to bring transparency to the agriculture value chain. We are a world-class team of engineers, scientists, and business professionals with expertise across data science, computational modeling, software design, agronomy, and biology.

We've pioneered remote, capillary whole blood collection with devices that are virtually painless and easy to use - at home or in clinical settings. Our devices produce high-quality blood samples at high volumes, making them ideal for decentralized clinical trials, wellness testing, and clinical-grade blood sampling.

Montai is unlocking the power of nature with digital technologies to treat and preempt chronic disease, improving health outcomes for as many people as possible.

Senda is founded on the insight that human and non-human cells coevolved to exchange molecules continually. Natural nanoparticles evolved to shuttle information biomolecules into human cells, displaying tropism, potency, and repeatability in their interactions. Senda is the first company to decode this natural programming language to unlock full programming to the cell.

Through a transformational plant breeding approach, we are creating a new horizon in agriculture that is more predictive, efficient, affordable, inclusive, and respectful of the environment.

Novomer’s synthetic chemical technology allows traditional chemical feedstocks to be combined with carbon dioxide or carbon monoxide to cost effectively synthesize sustainable chemicals and materials for a wide variety of applications. The chemicals and materials contain up to 50% by weight low cost waste carbon dioxide (CO2) or carbon monoxide (CO) and, as a result, have a significantly reduced carbon and energy footprint and advantaged economics as compared to the materials they will replace. Not only do the materials and chemicals offset the use of petroleum derived feedstocks, they also sequester the CO2 and CO for the life of the product, mitigating global warming and climate change.

Plants rely on a vast array of natural, beneficial microbes to support their health and productivity. The community of microbes living in and around a plant—its microbiome—works in harmony with the plant to provide life­-sustaining benefits throughout the plant’s lifecycle. They help the plant absorb nutrients in the soil and bolster its resilience to environmental stresses. Inspired by insights from the human microbiome, Indigo started with the hypothesis that microbes living inside the plant (endosymbionts) are vital to their health. But we found that some of these important microbes were being reduced by modern agricultural practices. By using sophisticated genomic sequencing and computational bioinformatics, Indigo has assembled what we believe is the world’s largest database of genomic information from these microbes

To improve the productivity and sustainability of the twenty-first-century farmer, Agrinos is helping shape the future of modern agriculture. The world needs innovative and sustainable solutions to increase agricultural output while reducing input in order to meet the needs of our growing global population. Agrinos’ global research, development and agronomy team is putting our innovative products at the forefront of microbial and biological crop input innovation.

BoMill is a company with profound know-how within quality sorting of wheat, durum wheat and barley using single kernel sorting technology. The BoMill head office is in the University town of Malmö, Sweden, only 15 minutes from Copenhagen airport. The company sells quality sorting technology and know-how throughout Europe, North America and Australia, using its own sales organization or agents/distributors.

PGT was founded in 2005 by Nobel Laureate Sydney Brenner and his colleagues Sam Eletr and Philip Goelet. Their vision was to create and commercialize nucleic acid biochemistry tools and approaches,referred to as “chemware” by Sydney, that would contribute to a better understanding of the inherent complexity of human, animal, plant and microbiological genomes. The founders realized that useful applications of genomic information would require acquiring and processing data from large numbers of samples of a population in order to draw statistically valid inferences about the role of genetics as a cause of traits or disease. To advance this vision, the Company from its inception focused its efforts on developing novel concepts that would take advantage of the enormous throughput of next generation sequencing (NGS) in the most efficient possible manner. Since PGT’s founding, a broad portfolio of over 30 patents have issued in the US, EU and other major markets.

Biognosys is the leading proteomics company offering innovative services and products for highly multiplexed protein quantification. Founded in 2008 as a spin-off from the lab of proteomics pioneer Ruedi Aebersold at ETH Zurich, Biognosys is dedicated to transforming the life sciences with superior proteomics solutions.

As the venture capital arm of Syngenta, one of the world's leading agribusiness companies, Syngenta Ventures is seeking to identify early stage companies with a strong technology base or new business model, or both, where our team of investment professionals, together with the support of our 25,000 colleagues across the world, can help build valuable businesses benefitting both Syngenta and the investee company stakeholders

Progenika’s mission is to improve healthcare through the development and commercialization of diagnostic and prognostic products to personalize the treatment of genetically complex diseases.

SCB is an early stage institutional venture capital fund

Najeti Capital operates in Europe investing on technology-driven, expansion projects. Najeti operates in France, Spain and the U.S.A. (Najeti Capital S.C.R., S.A. and Najeti Ventures LLC) using each of its head offices as permanent connections for international expansion and synergies development among the portfolio projects.

EYHER S.L. has been designing and manufacturing custom-made solutions for material handling equipment since 1953